Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

529 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An evaluation of the Japanese Society on Thrombosis and Hemostasis criteria for disseminated intravascular coagulation as a predictor of prognosis in patients with infection.
Madoiwa S, Honda G, Kawano N, Uchiyama T, Kawasugi K, Takezako N, Suzuki K, Seki Y, Ikezoe T, Okamoto K, Wada H. Madoiwa S, et al. Among authors: kawano n. Int J Lab Hematol. 2021 Dec;43(6):1566-1574. doi: 10.1111/ijlh.13643. Epub 2021 Jul 6. Int J Lab Hematol. 2021. PMID: 34228395
Clinical Features of Disseminated Intravascular Coagulation According to the French-American-British Classification in Patients With Acute Leukemia and Thrombomodulin Alfa Treatment-A Cohort Study Using a Postmarketing Surveillance Database.
Yoshinobu S, Honda G, Kawano N, Uchiyama T, Kawasugi K, Madoiwa S, Takezako N, Takayuki I, Wada H. Yoshinobu S, et al. Among authors: kawano n. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211054094. doi: 10.1177/10760296211054094. Clin Appl Thromb Hemost. 2021. PMID: 34870471 Free PMC article.
Analysis of the association between resolution of disseminated intravascular coagulation (DIC) and treatment outcomes in post-marketing surveillance of thrombomodulin alpha for DIC with infectious disease and with hematological malignancy by organ failure.
Kawano N, Wada H, Uchiyama T, Kawasugi K, Madoiwa S, Takezako N, Suzuki K, Seki Y, Ikezoe T, Hattori T, Okamoto K. Kawano N, et al. Thromb J. 2020 Feb 7;18:2. doi: 10.1186/s12959-020-0216-6. eCollection 2020. Thromb J. 2020. PMID: 32047363 Free PMC article.
Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa.
Kawasugi K, Wada H, Honda G, Kawano N, Uchiyama T, Madoiwa S, Takezako N, Suzuki K, Seki Y, Ikezoe T, Iba T, Okamoto K. Kawasugi K, et al. Among authors: kawano n. Thromb J. 2021 Feb 25;19(1):12. doi: 10.1186/s12959-021-00264-z. Thromb J. 2021. PMID: 33632246 Free PMC article.
Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study.
Mori H, Kataoka Y, Harada-Shirado K, Kawano N, Hayakawa M, Seki Y, Uchiyama T, Yamakawa K, Ishikura H, Irie Y, Nishio K, Yada N, Okamoto K, Yamada S, Ikezoe T. Mori H, et al. Among authors: kawano n. Thromb J. 2022 Jun 13;20(1):33. doi: 10.1186/s12959-022-00390-2. Thromb J. 2022. PMID: 35698137 Free PMC article.
Correction: Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study.
Mori H, Kataoka Y, Harada-Shirado K, Kawano N, Hayakawa M, Seki Y, Uchiyama T, Yamakawa K, Ishikura H, Irie Y, Nishio K, Yada N, Okamoto K, Yamada S, Ikezoe T. Mori H, et al. Among authors: kawano n. Thromb J. 2022 Aug 31;20(1):49. doi: 10.1186/s12959-022-00406-x. Thromb J. 2022. PMID: 36045367 Free PMC article. No abstract available.
Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
Kawano N, Tasaki A, Kuriyama T, Tahara Y, Yoshida S, Ono N, Himeji D, Yamashita K, Shibata Y, Goto T, Inoue T, Yokota-Ikeda N, Uezono S, Yuge A, Nishiguchi T, Kinjo T, Ogura Y, Beppu K, Ueda Y, Kinoshita M, Moritake H, Shimoda K, Ochiai H, Ueda A. Kawano N, et al. Intern Med. 2014;53(3):205-13. doi: 10.2169/internalmedicine.53.0715. Intern Med. 2014. PMID: 24492688 Free article.
Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture, Japan.
Matsunaga T, Yamashita K, Kubuki Y, Toyama T, Imataki O, Maeda K, Kawano N, Satou S, Kawano H, Ishizaki J, Yoshida S, Kameda T, Sasaki T, Sekine M, Kamiunten A, Taniguchi Y, Hidaka T, Katayose K, K-Shimoda H, Shide K, Yamamoto S, Moritake H, Nunoi H, Makino S, Kitanaka A, Matsuoka H, Shimoda K. Matsunaga T, et al. Among authors: kawano n, kawano h. Int J Hematol. 2012 Sep;96(3):342-9. doi: 10.1007/s12185-012-1146-2. Epub 2012 Jul 24. Int J Hematol. 2012. PMID: 22825970
Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N, Yoshida S, Ono N, Himeji D, Nagahiro Y, Sayaka Kawano, Yamashita K, Ikeda N, Uezono S, Ochiai H, Kawano F, Kikuchi I, Ishikawa F, Shimoda K, Ueda A, Akashi K. Kawano N, et al. Among authors: kawano f. J Clin Exp Hematop. 2011;51(2):101-7. doi: 10.3960/jslrt.51.101. J Clin Exp Hematop. 2011. PMID: 22104308 Free article.
529 results